Results 321 to 330 of about 755,044 (345)

Evolutionary Selection and Constraint on Human Knee Chondrocyte Regulation Impacts Osteoarthritis Risk

Cell, 2020
Ata M Kiapour, Evelyn Jagoda, Jakob T Sieker   +2 more
exaly  

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

Lancet, The, 2009
Scott D Berkowitz, Sam Schulman
exaly  

The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial

Lancet, The, 2019
David J Beard, Andrew Price, Seamus Kent
exaly  

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Lancet, The, 2010
Alexander S Gallus, Gary Raskob
exaly  

The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study

Lancet, The, 2017
Sion Glyn-Jones, Dani Prieto-Alhambra, Andrew Judge   +2 more
exaly  

Knee Osteoarthritis Detection

Knee osteoarthritis is a degenerative joint disease that affects mobility and quality of life, particularly in aging populations. Traditional diagnosis relies heavily on manual interpretation of X-ray images, which can be subjective and time-intensive.
openaire   +1 more source

45-day mortality after 467 779 knee replacements for osteoarthritis from the National Joint Registry for England and Wales: an observational study

Lancet, The, 2014
Linda P Hunt, Yoav Ben-Shlomo, Andrew Judge   +2 more
exaly  

Adverse outcomes after total and unicompartmental knee replacement in 101 330 matched patients: a study of data from the National Joint Registry for England and Wales

Lancet, The, 2014
Andrew Judge, Hemant Pandit, David Murray   +2 more
exaly  

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

Lancet, The, 2002
Bengt I Eriksson
exaly  

Tolerability and efficacy of tapentadol extended release in elderly patients ≥ 75 years of age with chronic osteoarthritis knee or low back pain.

Journal of Opioid Management, 2015
D. Biondi, J. Xiang, M. Etropolski, B. Moskovitz   +3 more
semanticscholar   +1 more source